Oric Pharmaceuticals, Inc. (ORIC)
8.89
+1.42
(+18.93%)
USD |
NASDAQ |
Apr 02, 16:00
8.80
-0.09
(-1.01%)
After-Hours: 20:00
Oric Pharmaceuticals Research and Development Expense (TTM) : 109.82M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Amgen, Inc. | 7.281B |
| Krystal Biotech, Inc. | 55.08M |
| Olema Pharmaceuticals, Inc. | 157.70M |
| Tango Therapeutics, Inc. | 130.51M |
| Tyra Biosciences, Inc. | 102.38M |